Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Wednesday, February 10, 2010, 3:08PM AEST - The Australian Stockmarket closes in 57 minutes.
To create a watchlist or portfolio of shares,
Register
FINANCE HOME PAGE
INVESTING
FINANCE NEWS
PERSONAL FINANCE
SMALL BUSINESS
Enter symbol(s):
Symbol Lookup
|
Exchanges
Search News:
3SBio Inc. (SSRX)
8:00AM AEST:
10.18 USD
0.07 (0.68%)
MORE ON SSRX
Quotes
Summary
Options
Historical Prices
Charts
Basic Chart
Technical Chart
Technical Analysis
Detailed Data
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
3SBio Inc.
(NasdaqNM:SSRX) Delayed quote data
Last Trade:
10.18 USD
Trade Time:
8:00AM AEST
Change:
0.07 (0.68%)
Prev Close:
10.25
Open:
10.25
Bid:
9.18
x 200
Ask:
N/A
1y Target Est:
14.75
Day's Range:
10.15 - 10.35
52wk Range:
4.18 - 14.45
Volume:
165,450
Avg Vol
(3m)
:
98,919
Market Cap:
219.06M
P/E
(ttm)
:
N/A
EPS
(ttm)
:
N/A
Div & Yield:
N/A (N/A%)
1d
5d
3m
6m
1y
2y
5y
Add SSRX to Portfolio
Download Data
HEADLINES
3SBio Gains China Rights to Another Dialysis Drug
at Seeking Alpha
(Tue 6:43PM)
3SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemia
PR Newswire
(Mon, Feb 8)
3SBio Inc. to Report 2009 Fourth Quarter and Full Year Results on February 11, 2010
PR Newswire
(Tue, Jan 26)
2 Stocks Hitting Low Notes
at Motley Fool
(Tue, Jan 26)
AMAG Pharma Guides on Feraheme
Zacks.com
(Tue, Jan 12)
China Biotech Week in Review: New Investments for a New Year
at Seeking Alpha
(Sun, Jan 10)
3SBio Inc. Applies for SFDA Registrational Trial for Feraheme(TM)
PR Newswire
(Fri, Jan 8)
Prospecting for Stocks: QLT
at Motley Fool
(Thu, Dec 17)
The Wrong Way to Invest in China
at Motley Fool
(Fri, Dec 11)
Build Your Fortune With These Winners
at Motley Fool
(Fri, Dec 4)
Biotech Bargains for Your Portfolio
at Motley Fool
(Sat, Nov 28)
3SBIO INC Earnings Call scheduled for 8:00 am ET today
CCBN
(Sat, Nov 14)
3SBio Inc. Announces Unaudited Third Quarter 2009 Results
PR Newswire
(Fri, Nov 13)
More Headlines for SSRX...
ANALYST
EPS Est (next year)
(Dec-09)
:
0.56
EPS Est (in 2 years)
(Dec-10)
:
0.65
Avg Rec (current)*:
1.5
PEG Ratio:
1.50
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion
-
Estimates
BUSINESS SUMMARY
3SBio Inc., a biotechnology company, focuses on the research, development, manufacture, and marketing of biopharmaceutical products primarily in the Peoples Republic of China.
Full Company Profile
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Australia
New Zealand
US
----------------
Argentina
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Malaysia
Mexico
Netherlands
Norway
Singapore
South Korea - Korea
South Korea - KOSDAQ
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Symbol Lookup
Latest News
7 Indices